HLPPX
Price
$9.71
Change
-$0.00 (-0.00%)
Updated
Aug 15 closing price
Net Assets
11.64M
VGSLX
Price
$127.04
Change
+$0.67 (+0.53%)
Updated
Aug 15 closing price
Net Assets
63.72B
Interact to see
Advertisement

HLPPX vs VGSLX

Header iconHLPPX vs VGSLX Comparison
Open Charts HLPPX vs VGSLXBanner chart's image
LDR Real Estate Value Opportunity P
Price$9.71
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets11.64M
Vanguard Real Estate Index Admiral
Price$127.04
Change+$0.67 (+0.53%)
VolumeN/A
Net Assets63.72B
HLPPX vs VGSLX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
HLPPX vs. VGSLX commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLPPX is a Buy and VGSLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VGSLX has more cash in the bank: 63.7B vs. HLPPX (11.6M). VGSLX pays higher dividends than HLPPX: VGSLX (3.89) vs HLPPX (1.83). HLPPX was incepted earlier than VGSLX: HLPPX (16 years) vs VGSLX (24 years). HLPPX (3.03) is less costly to investors than VGSLX (0.13). HLPPX is a more actively managed with annual turnover of: 58.24 vs. VGSLX (7.00). HLPPX has a lower initial minimum investment than VGSLX: HLPPX (2500) vs VGSLX (3000). VGSLX annual gain was more profitable for investors over the last year : 1.89 vs. HLPPX (-10.28). VGSLX return over 5 years is better than : 33.64 vs. HLPPX (-3.75).
HLPPXVGSLXHLPPX / VGSLX
Total Expense Ratio3.030.132,331%
Annual Report Gross Expense Ratio3.030.132,331%
Fund Existence16 years24 years-
Gain YTD-9.2012.589-355%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets11.6M63.7B0%
Annual Yield % from dividends1.833.8947%
Returns for 1 year-10.281.89-545%
Returns for 3 years-17.25-0.0918,788%
Returns for 5 years-3.7533.64-11%
Returns for 10 years-31.8956.65-56%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KPTI5.921.27
+27.31%
Karyopharm Therapeutics Inc.
CRL156.680.88
+0.56%
Charles River Laboratories International
CUB10.500.01
+0.10%
Lionheart Holdings
OACCU10.57N/A
N/A
Oaktree Acquisition Corp III Life Sciences
TRS36.77-0.20
-0.54%
TriMas Corp